S-riseroprevalence of TORCH Infections among highk pregnant women, Datia, Madhya Pradesh
Bioinformation · 28.02.2026 · 22 (2) · 940-942
DOI: 10.6026/973206300220940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 28.02.2026. Verfasst von Abhishek Mehta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Government Medical College, Datia, Madhya Pradesh, India. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The lack of data on the seroprevalence of TORCH infections among high-risk pregnant women in Datia, Madhya Pradesh, which is crucial for better maternal and fetal health outcomes, is a concern. Over six months, 50 serum samples were tested for IgM antibodies using immunochromatographic rapid card tests. Data show that 28% of women were positive for at least one infection, with CMV being the most common (16%). No co-infections were found. Thus, we show the effectiveness of ICT/RCT for rapid screening and emphasize the importance of TORCH screening in high-risk pregnancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Government Medical College, Datia, Madhya Pradesh, India.
- Department of Pediatrics, Government Medical College, Datia, Madhya Pradesh, India.
Zitieren
APA
Mehta, A., Gupta, A., & Agrawal, P. (2026). S-riseroprevalence of TORCH Infections among highk pregnant women, Datia, Madhya Pradesh. Bioinformation, 22(2), 940-942. https://doi.org/10.6026/973206300220940
Vancouver
Mehta A, Gupta A, Agrawal P. S-riseroprevalence of TORCH Infections among highk pregnant women, Datia, Madhya Pradesh. Bioinformation. 2026;22(2):940-942. doi:10.6026/973206300220940
BibTeX
@article{Mehta2026,
author = {Mehta, Abhishek and Gupta, Abha and Agrawal, Puneet},
title = {S-riseroprevalence of TORCH Infections among highk pregnant women, Datia, Madhya Pradesh},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {2},
pages = {940--942},
doi = {10.6026/973206300220940}
}
EUVIMED